Recommendations for Prevention and Control of Influenza in Children, 2019-2020

Pediatrics. 2019 Oct;144(4):e20192478. doi: 10.1542/peds.2019-2478. Epub 2019 Sep 2.

Abstract

This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019-2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication continues to be recommended for children with suspected or confirmed influenza, particularly those who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza.

Publication types

  • Practice Guideline

MeSH terms

  • Adolescent
  • Age Factors
  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / adverse effects
  • Breast Feeding
  • Cause of Death
  • Child
  • Child, Hospitalized
  • Child, Preschool
  • Contraindications
  • Disease Progression
  • Drug Resistance, Viral
  • Egg Hypersensitivity
  • Female
  • Humans
  • Immunocompromised Host
  • Infant
  • Influenza A Virus, H1N1 Subtype / immunology
  • Influenza A Virus, H3N2 Subtype / immunology
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / adverse effects
  • Influenza, Human / complications
  • Influenza, Human / drug therapy*
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control*
  • Pediatrics
  • Pregnancy
  • United States / epidemiology
  • Vaccines, Inactivated / administration & dosage

Substances

  • Antiviral Agents
  • Influenza Vaccines
  • Vaccines, Inactivated